Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-18-009128)

Filing Details

Accession Number:: 0001213900-18-009128
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-12 17:11:48
Reporting Period:: 2018-07-10

Accepted Time:: 2018-07-12 17:11:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1176309	Oramed Pharmaceuticals Inc.	ORMP	Pharmaceutical Preparations (2834)	980376008

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1351779	Nadav Kidron	142 W. 57Th St. New York NY 10019	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-07-10	61	$5.98	958,087	No	4	S	Direct
Common Stock	Acquisiton	2018-07-11	122	$5.92	958,209	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	P	Direct

Footnotes

On July 12, 2018, Mr. Kidron paid to Oramed Pharmaceuticals Inc. $3.88, representing the full amount of the profit realized in connection with these short-swing transactions.